No difference in the levels of C3 were recorded in AATD patients’ plasma compared to HC samples [19], and thus the aim of this experiment was to determine activation of C3 by NE in the setting of AATD with low plasma levels of AAT protein. This evidence concerns the gene C3 and alpha 1-antitrypsin deficiency.